Why timestamp drift between wearable sensors quietly undermines decentralized trial data, and why almost no one is asking about it.
- Why Clinical Trial Coordinators Are Still The Human API
- The Cost And ROI Of Agentic AI In Clinical Trials: What Sponsors And CROs Need To Know
- Designing eCOA Technology Patients Can Actually Use
- Clinical Trial Technology Doesn't Fail – It Fails At The Handoff
- Why Life Science Tech Pilots Fail After The Demo — And How To Avoid It
- Inside Versiti's Data Strategy: Building AI-Ready Research Systems
- How Versiti Turns Data Into A Lifeline For Rare Blood Patients
- What Is Shadow AI, And How Does It Impact Clinical Trial Tech?
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
The Future Of Data Linkage In Clinical Trial Evidence Generation
Explore key questions about the future of AI and data linkage in clinical trial evidence generation.
-
Opportunities For Enhancing Signal Detection In Schizophrenia Trials
Signal detection in schizophrenia trials is hindered by increased placebo response, complex rating scales, inconsistent rater performance, and data quality issues.
-
How Paper And Electronic Source Data Meet ALCOA-C Principles
According to the Food and Drug Administration (FDA), data should meet certain fundamental elements of quality. If these best practices for source documentation aren’t followed, there is no valid evidence the test article is safe and effective.
-
Outsourcing Data Management: Challenges And Benefits
Life sciences companies are grappling with a deluge of data. Yet strategic data management outsourcing offers potential benefits amidst regulatory and interoperability hurdles.
-
A Blueprint For Modern Obesity Research
The landscape of obesity and GLP-1 research has reached a saturation point. To successfully scale to the 5,000-patient registries now required for long-term evidence, a shift in operational architecture is essential.
-
Evaluating Wearable Data Platforms For Endpoint-Driven Studies
Endpoint‑driven studies need platforms that unify wearable data with trial systems, support derived measures, and ensure traceability so continuous data becomes reliable clinical evidence.
-
Drive Superior Enrollment, Speed, And Quality Using eSource
Explore a detailed analysis of 140 research sites involved in a Phase III trial, highlighting significant advancements in trial performance and data quality using CRIO’s eSource platform.
-
Understanding Decentralized Clinical Trials: FDA vs. EMA Fundamentals
Designing a global decentralized clinical trial requires understanding the differing FDA and EMA approaches to trial models and informed consent.
-
Standardize Vaccine Study Launch Timelines To Just 5 Weeks
Uncover the pre-built vaccine trial solution that delivers quality and predictability for your entire immunology portfolio.
-
Bringing Expertise To Clinical Trials
Discover how Veristat achieved improved efficiency and enhanced control over its clinical trials.
- The Synchronization Problem Clinical Research Isn't Watching
- Why Ophthalmology Trials Are Clinical Research's Toughest Tech Test
- Why Trustworthy Clinical Trial Data Starts As Analog, Not Digital
- Why Clinical Trial Coordinators Are Still The Human API
- Designing eCOA Technology Patients Can Actually Use
RECENT NEWSLETTERS
- 08.01.26 -- July's Top Clinical Trial Tech Reads
- 07.30.26 -- Clinical Tech Leadership: Site Burden, AI ROI, And Smarter Trial Tech
- 07.23.26 -- AI, Data Costs, And The Real Barriers To Trial Execution
- 07.16.26 -- Why Clinical Trial Sites Are Drowning In Tech Chaos
- 07.09.26 -- AI Governance, Real-Time Trials, And Hidden Risks to Watch